Linshan Shen, Xuwei Zhang, Shaobin Huang, Bing Wu, Jingjie Li
{"title":"A diagnostic method for cardiomyopathy based on multimodal data.","authors":"Linshan Shen, Xuwei Zhang, Shaobin Huang, Bing Wu, Jingjie Li","doi":"10.1515/bmt-2023-0099","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Currently, a multitude of machine learning techniques are available for the diagnosis of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) by utilizing electrocardiography (ECG) data. However, these methods rely on digital versions of ECG data, while in practice, numerous ECG data still exist in paper form. As a result, the accuracy of the existing machine learning diagnostic models is suboptimal in practical scenarios. In order to enhance the accuracy of machine learning models for diagnosing cardiomyopathy, we propose a multimodal machine learning model capable of diagnosing both HCM and DCM.</p><p><strong>Methods: </strong>Our study employed an artificial neural network (ANN) for feature extraction from both the echocardiogram report form and biochemical examination data. Furthermore, a convolutional neural network (CNN) was utilized for feature extraction from the electrocardiogram (ECG). The resulting extracted features were subsequently integrated and inputted into a multilayer perceptron (MLP) for diagnostic classification.</p><p><strong>Results: </strong>Our multimodal fusion model achieved a precision of 89.87%, recall of 91.20%, F1 score of 89.13%, and precision of 89.72%.</p><p><strong>Conclusions: </strong>Compared to existing machine learning models, our proposed multimodal fusion model has achieved superior results in various performance metrics. We believe that our method is effective.</p>","PeriodicalId":8900,"journal":{"name":"Biomedical Engineering / Biomedizinische Technik","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical Engineering / Biomedizinische Technik","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1515/bmt-2023-0099","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Currently, a multitude of machine learning techniques are available for the diagnosis of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM) by utilizing electrocardiography (ECG) data. However, these methods rely on digital versions of ECG data, while in practice, numerous ECG data still exist in paper form. As a result, the accuracy of the existing machine learning diagnostic models is suboptimal in practical scenarios. In order to enhance the accuracy of machine learning models for diagnosing cardiomyopathy, we propose a multimodal machine learning model capable of diagnosing both HCM and DCM.
Methods: Our study employed an artificial neural network (ANN) for feature extraction from both the echocardiogram report form and biochemical examination data. Furthermore, a convolutional neural network (CNN) was utilized for feature extraction from the electrocardiogram (ECG). The resulting extracted features were subsequently integrated and inputted into a multilayer perceptron (MLP) for diagnostic classification.
Results: Our multimodal fusion model achieved a precision of 89.87%, recall of 91.20%, F1 score of 89.13%, and precision of 89.72%.
Conclusions: Compared to existing machine learning models, our proposed multimodal fusion model has achieved superior results in various performance metrics. We believe that our method is effective.
期刊介绍:
Biomedical Engineering / Biomedizinische Technik (BMT) is a high-quality forum for the exchange of knowledge in the fields of biomedical engineering, medical information technology and biotechnology/bioengineering. As an established journal with a tradition of more than 60 years, BMT addresses engineers, natural scientists, and clinicians working in research, industry, or clinical practice.